# Prednisolone Addition for Patients With Recent-onset Psychotic Disorder

> **NCT02949232** · PHASE4 · TERMINATED · sponsor: **UMC Utrecht** · enrollment: 42 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder
- Schizophreniform Disorder
- Psychotic Disorder NOS

## Interventions

- **DRUG:** Prednisolone
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT02949232
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** Difficulties with recruitment
- **Last updated:** 2019-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02949232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02949232, "Prednisolone Addition for Patients With Recent-onset Psychotic Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02949232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*